Compare, Analyse GSK Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ACTAVIS (US) - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   ACTAVIS
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
ACTAVIS
Dec-18
GSK PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs3,59514,487-   
Low Rs1,2539,718-   
Sales per share (Unadj.) Rs184.73,553.7-  
Earnings per share (Unadj.) Rs26.3-1,144.7-  
Cash flow per share (Unadj.) Rs29.2374.5-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs126.314,657.5-  
Shares outstanding (eoy) m169.40332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x13.13.4 385.4%   
Avg P/E ratio x92.2-10.6 -871.9%  
P/CF ratio (eoy) x83.132.3 257.2%  
Price / Book Value ratio x19.20.8 2,324.0%  
Dividend payout %76.10-   
Avg Mkt Cap Rs m410,6264,025,370 10.2%   
No. of employees `0005.016.9 29.3%   
Total wages/salary Rs m5,3720-   
Avg. sales/employee Rs Th6,306.769,939.2 9.0%   
Avg. wages/employee Rs Th1,083.10-   
Avg. net profit/employee Rs Th898.0-22,527.5 -4.0%   
INCOME DATA
Net Sales Rs m31,2811,181,973 2.6%  
Other income Rs m1,02322,603 4.5%   
Total revenues Rs m32,3041,204,576 2.7%   
Gross profit Rs m6,00930,974 19.4%  
Depreciation Rs m486505,268 0.1%   
Interest Rs m668,207 0.0%   
Profit before tax Rs m6,540-519,897 -1.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m287132,595 0.2%   
Tax Rs m2,373-6,589 -36.0%   
Profit after tax Rs m4,454-380,714 -1.2%  
Gross profit margin %19.22.6 733.0%  
Effective tax rate %36.31.3 2,863.2%   
Net profit margin %14.2-32.2 -44.2%  
BALANCE SHEET DATA
Current assets Rs m20,061484,783 4.1%   
Current liabilities Rs m14,543428,855 3.4%   
Net working cap to sales %17.64.7 372.8%  
Current ratio x1.41.1 122.0%  
Inventory Days Days5720 289.9%  
Debtors Days Days1466 21.2%  
Net fixed assets Rs m14,343133,793 10.7%   
Share capital Rs m1,6940-   
"Free" reserves Rs m19,7040-   
Net worth Rs m21,3984,875,085 0.4%   
Long term debt Rs m21,716,694 0.0%   
Total assets Rs m39,1137,620,868 0.5%  
Interest coverage x1,091.0-6.6 -16,474.4%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.2 515.7%   
Return on assets %11.4-4.1 -278.1%  
Return on equity %20.8-7.8 -266.5%  
Return on capital %31.9-4.8 -659.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-6,5570-   
CASH FLOW
From Operations Rs m3,994422,274 0.9%  
From Investments Rs m-1,433231,985 -0.6%  
From Financial Activity Rs m-3,584-724,749 0.5%  
Net Cashflow Rs m-1,023-70,138 1.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 74.87 Rs / USD

Compare GSK PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare GSK PHARMA With: GLENMARK PHARMA  CIPLA  AJANTA PHARMA  PROCTER & GAMBLE HEALTH  LUPIN  



Today's Market

Sensex Ends 244 Points Lower, Nifty Ends Below 14,300; UltraTech Cement & HCL Tech Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views On News

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Top 3 Nifty ETFs to Buy Now (Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

GSK PHARMA SHARE PRICE


Apr 20, 2021 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

GSK PHARMA 8-QTR ANALYSIS

COMPARE GSK PHARMA WITH

FEATURED VIDEOS

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

More Featured Videos

MARKET STATS